Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice

  • Acta Pharm Sin B. 2024 Sep;14(9):4189-4192. doi: 10.1016/j.apsb.2024.07.001.
Mianling Yang  1 ,  Meehyein Kim  2 ,  Peng Zhan  1
Affiliations
  • 1. Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Ji'nan 250012, China.
  • 2. Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.
PMID: 39309490 DOI: 10.1016/j.apsb.2024.07.001
Keywords
Anti-drug resistance; Broad-spectrum; Drug candidate; Papain-like protease; SARS-CoV-2.
Products